Bard Agrees to Acquire Liberator Medical

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) announced today that it has entered into a definitive agreement to acquire Liberator Medical Holdings, Inc. (NYSEMKT: LBMH) (Liberator) for $3.35 per share, or approximately $181 million. This transaction is structured as a merger, has been approved by each company’s board of directors, and is subject to customary closing conditions, including approval of the shareholders of Liberator and regulatory approvals.